]>
IRCT2015082623766N1 IRCT 2015-09-14 vice chancellor for research of Ahwaz Jondishapour University of Medical Sciences Haloperidol and Risperidone efficacy for Attention Deficit Hyperactivity Disorder treatment Comparison of Risperidon versus Haloperidol in the treatment of preschool children with attention deficit hyperactivity disorder 2014-03-20 anticipated 46 Complete https://irct.ir/trial/20253 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment. N/A Attention deficit hyperactivity disorder. Intervention 1: The second group took haloperidol orally with a starting dose of 0.5mg in two divided doses and it was increased depending on clinical response and tolerability. The maximum dose for haloperidol was 0.075mg/kg at the end of sixth week. Intervention 2: The first group took Risperidone tablet orally at the starting dose of 0.25mg and it was increased depending on clinical response and the maximum dose was 2mg at the end of sixth week.
public Leila Abdi
Psychiatry department, Golestan hospital, Golestan Boulevard
Ahwaz Iran (Islamic Republic of) +98 61 3391 7249 Leilaabdi1635@gmail.com Ahwaz Jondishapour University of Medical Sciences scientific Leila Abdi
Department of psychiatry, Golestan hospital, Golestan Boulevard
Ahwaz Iran (Islamic Republic of) +98 61 3391 7249 Leilaabdi1635@gmail.com Ahwaz Jondishapour University of Medical Sciences Iran (Islamic Republic of) inclusion criteria: three to six years old children with attention deficit hyperactivity disorder; parent consent; ADHD rating scale greater than 20 and C-GAS lower than 50. exclusion criteria:any other medical or psychiatric comorbidity like mood disorder; anxiety disorder; mental retardation; psychotic disorder; tic; pervasive developemental disorder and taking any pharmacological or non pharmacological treatment in two weeks prior to study. 3 years 6 years Both F90 hyperkinetic disorder Treatment - Drugs Treatment - Drugs The second group took haloperidol orally with a starting dose of 0.5mg in two divided doses and it was increased depending on clinical response and tolerability. The maximum dose for haloperidol was 0.075mg/kg at the end of sixth week. The first group took Risperidone tablet orally at the starting dose of 0.25mg and it was increased depending on clinical response and the maximum dose was 2mg at the end of sixth week. Attention deficit hyperactivity disorder score. Timepoint: baseline and 2 weeks, 4weeks, 6weeks after intervention. Method of measurement: Attention deficit hyperactivity disorder rating scale questionarie. Children's Global Assessment. Timepoint: baseline and 6 weeks after intervention. Method of measurement: Children's Global Assessment Scale questionarie. Attention deficit hyperactivity disorder score. Timepoint: baseline and 2 weeks, 4weeks, 6 weeks after intervention. Method of measurement: Conners Rating Scale-Parent version questionarie. Drug side effects. Timepoint: 2 weeks, 4weeks, 6weeks after intervention. Method of measurement: Side effect questionaire. vice chancellor for research of Ahwaz Jondishapour University of Medical Sciences Approved 2014-12-06 Ethics committee of Ahwaz Jondishapour University of Medical Sciences Ethics Committee of Jondishapour University of Medical Sciences, university center, Golestan Boulevard Ahwaz Iran (Islamic Republic of)